A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling by Muranaka H et al.
A distinct function of the retinoblastoma
protein in the control of lipid composition
identified by lipidomic profiling
著者 Muranaka H, Hayashi A, Minami K, Kitajima S,
Kohno S, Nishimoto Y, Nagatani N, Suzuki M,
Kulathunga L A N, Sasaki N, Okada N, Matsuzaka
T, Shimano H, Tada H, Takahashi C
journal or
publication title
Oncogenesis
volume 6
number 6
page range e350
year 2017-06
権利 (C) The Author(s) 2017
Oncogenesis is an open-access journal
published by Nature Publishing Group. This
work is licensed under a Creative Commons
Attribution 4.0 International License. The
images or other third party material in this
article are included in the article’s
Creative Commons license, unless indicated
otherwise in the credit line; if the material
is not included under the Creative Commons
license, users will need to obtain permission
from the license holder to reproduce the
material. To view a copy of this license,
visit
http://creativecommons.org/licenses/by/4.0/
URL http://hdl.handle.net/2241/00150938
doi: 10.1038/oncsis.2017.51
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
OPEN
ORIGINAL ARTICLE
A distinct function of the retinoblastoma protein in the control
of lipid composition identiﬁed by lipidomic proﬁling
H Muranaka1, A Hayashi2, K Minami3, S Kitajima1,4, S Kohno1, Y Nishimoto1, N Nagatani1, M Suzuki1, LAN Kulathunga1, N Sasaki1,5,
N Okada1, T Matsuzaka6, H Shimano6, H Tada7 and C Takahashi1
Here, by combining lipidomics with transcriptome analysis, we demonstrate that Rb depletion in mouse embryonic
ﬁbroblastss induces signiﬁcant alterations in their lipid composition. We discovered that Rb depletion induced increase in
lysophosphatidylserine, diacylglycerol (DAG), fatty acid (FA), acylcarnitine, phosphatidylcholine (PC), arachidonoyl ethanolamine,
and decrease in phosphatidylglycerol, monoacylglycerol, without change in total lipid per protein levels. Analysis of the acyl chain
composition of DAG, PC and phosphatidylserine revealed increase of saturated and mono-unsaturated acyl chains with speciﬁc
carbon chain length. Consistently, we observed that Rb depletion increased the levels of fatty acids with the corresponding carbon
chain length and number of carbon–carbon double bondssuch as myristic acid (14:0), palmitic acid (16:0), stearic acid (18:0) and all
forms of FA 18:1. Microarray analysis revealed that Rb depletion induced signiﬁcant upregulation of enzymes involved in elongation
and desaturation of fatty acids. Among these, we found that elongation of long chain fatty acid family member 6 (Elovl6) and
stearoyl-CoA desaturase 1 (Scd1) are the most robustly controlled by Rb possibly through E2F and sterol regulatory element-
binding protein transcription factors. Depletion of Elovl6 or Scd1 signiﬁcantly suppressed colony formation, sphere formation and
xenograft tumor growth of Rb-deﬁcient tumor cells. Suppression of self-renewal by the SCD1 inhibitor was rescued upon
supplementation of the mono-unsaturated fatty acids generated by this enzyme. This study suggests a novel role for Rb in
suppressing the malignant progression of tumors by controlling the lipid composition.
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INTRODUCTION
Components of the Rb pathway are functionally inactivated in the
majority of human malignancies.1 The canonical function of Rb
has been attributed to its ability to control the G1-S transition
by interacting with the E2F transcription factors.2,3 In addition to
E2Fs, the Rb protein (pRb) interacts with a variety of transcription
factors and chromatin modiﬁers.4 The heterogeneity of binding
partners exceeding 300 proteins may underlie pleiotropic pRb
functions exerted beyond cell cycle control including control
of differentiation, apoptosis, genomic stability, senescence,
angiogenesis and metastasis.1
More recently, emerging evidence suggests new roles for Rb in
cellular metabolism, such as autophagy, glycolysis, glutaminolysis,
insulin secretion, mitochondrial biogenesis, mitochondrial oxida-
tive phosphorylation (OXPHOS), mitochondrial reactive oxygen
species metabolism and mitochondrial protein translation.5–10
Presumably, pRb exerts its metabolic functions largely through
E2F transcription factors.
We reported that pRb controls the N-Ras activation status
through protein isoprenylation (lipid modiﬁcation).11,12 This
function of pRb appeared to be mediated dually by E2Fs and
sterol regulatory element-binding proteins (SREBPs). Since SREBPs
control the transcription of a variety of lipogenic genes,13
we hypothesized a distinct role for pRb in lipid metabolism.
Increased de novo lipogenesis is an early and common event in
the development of cancer.14 Lipogenesis plays important roles
in many biological processes such as generation of building
blocks for membrane. Increased expression of lipogenic enzymes
including ATP citrate lyase (ACLY), acetyl-CoA carboxylase A
(ACACA) and fatty acid synthase (FASN) is correlated with poor
prognosis in many types of cancer.14–18 In addition, numerous
studies focused on the role for individual lipid metabolism
enzymes in cancer.
On the other hand, given the importance of comprehending
lipid composition globally, a new approach, lipidomics has
emerged as a powerful tool to understand lipid metabolism.19,20
Indeed, recent lipidomics studies revealed a dynamic alteration of
the membrane lipid composition in human cancer tissues,21 and
distinct lipid proﬁles correlated with tumor grade.22 Moreover,
combination of molecular biology and lipidomics techniques
revealed some of the mechanisms underlying deregulated lipid
metabolism in cancer.23–27
Here, we integrated lipidomics studies with transcriptome
analysis to uncover the role of Rb in lipid metabolism. We
demonstrate that depletion of Rb in mouse embryonic ﬁbroblast
(MEFs) induced distinct changes in the lipid proﬁles. By analyzing
the transcriptome in parallel, we identiﬁed a set of genes whose
changes in regulation may underlie the emergence of the distinct
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lipidomic changes upon Rb depletion. Finally, we investigated the
roles of these genes in malignant behaviors of cancer cells that are
exerted in an Rb-dependent manner. The information described in
this study indicates that Rb suppresses malignant behaviors of
tumor cells at least partially by controlling their lipid composition.
RESULTS
Lipid proﬁling of Rb-depleted MEFs
To investigate the effect of Rb status on lipid metabolism, we
employed the ultra-high performance liquid chromatography-
scheduled multiple reaction monitoring lipidomics technique,28
and analyzed MEFs infected with lentivirus either expressing Rb
shRNA or control shRNA. The speciﬁc effect of our Rb shRNA has
already been validated by the provider and in a previous report
from our group.29 Endogenous Rb1 levels were suppressed by
about 70% by Rb shRNA (Figure 1a). Rb-depleted MEFs exhibited
relatively higher proliferation rate as expected (Supplementary
Figure S1a). Rb-depleted MEFs and control MEFs were cultured in
the medium containing 1% fetal bovine serum for 24 h before
sample collection in one aim to minimize the effect of serum-
derived lipids on the cellular lipid proﬁle. Another aim of
this treatment was to activate Rb protein in control cells.
Representative mass spectra of control MEFs are shown
(Supplementary Figure S1b). We analyzed four batches of
wild-type MEFs from one embryo per one shRNA. After the data
pre-processing, targeted lipid proﬁling identiﬁed a total of
582 lipids in both cell types (Figure 1b). To facilitate the initial
multi- and uni-variate comparison of Rb-depleted and control
MEFs, we reduced the number of lipids to be analyzed to 199 by
removing those with a s.d.⩾ 30% and selecting the 10 most
abundant of each lipid class (Supplementary Table S1).
Principal component analysis, which indicates variability
among groups of numbers, revealed a clear difference between
Rb-depleted and control MEFs in terms of lipid proﬁles (Figure 1c).
The partial least square discriminant analysis score plot, which is
highly related to principal component analysis, also exhibited a
clear difference (Supplementary Figure S1c). Of 199 lipids, 96
showed variable importance in the projection (VIP) values
(indicating importance of each variable in the variability among
groups of numbers) of41 (Supplementary Table S2). The
metabolic shift after Rb depletion was further conﬁrmed by
hierarchical clustering analysis of 199 lipids (Figure 1d) and
25 lipids with the highest VIP scores (Supplementary Figure S1d).
The heat map of the top 20 VIPs indicated the metabolites
most inﬂuential in generating the variability observed; these
included diacylglycerol (DAG) 36:2, acylcarnitine (AcCar) 17:0,
AcCar 18:0, DAG 34:0, DAG 32:0, DAG 36:1, Cer (d18:1/22:1),
phosphatidylserine (PSa) 38:1, phosphatidylcholine (PCa) 36:1 and
lysophosphatidylserine (LPSa) 16:0 that are commonly composed
of C16:0, C16:1, C17:0, C18:0 or C18:1 fatty acyl chains (carbon
chain length: number of carbon–carbon double bonds)
(Figure 1e). It is worth noting that FA 18:1 also increased in
Rb-depleted MEFs. Next, we generated the volcano plot
(indicating fold change together with signiﬁcance) of the
− log10 (p) versus log2 (FC) values (Rb-depleted versus control
MEFs) of all variables with VIP41, and visualized the important
variables with Po0.05 and |FC|41.5 (indicated with red)
(Figure 1f). Among these, lipids with Po0.01 and |FC|42 were
shown in Figure 1g and Supplementary Figure S1e. The
upregulated compositions contained LPSa 18:0, LPSa 22:1, DAG
34:0, DAG 36:1, DAG 36:2, ethanolamine (AEA) 24:0 and AcCar 17:0,
while the downregulated ones contained PAa 38:4 and mono-
acylglycerol (MAG) 20:4. We detected again many of those
upregulated (LPSa18:0, DAG 34:0, DAG 36:1, DAG 36:2 and AcCar
17:0) are chieﬂy composed of speciﬁc acyl chains including C16:0,
C16:1, C17:0, C18:0 or C18:1.
Rb depletion induces a shift of acyl chain composition in
diacylglycerol
In addition to the signiﬁcant increase in speciﬁc LPS and DAG
species, we observed marked increase in the total amount of LPS
and DAG upon Rb depletion (Figures 2a and b). We also found
signiﬁcant increase in the total amount of FA, AcCar, PC and
ethanolamine (Figures 2a and b). On the other hand, the amount
of phosphatidylglycerol and MAG decreased signiﬁcantly
(Figures 2a and b). However, these changes occurred without
alterations in total lipid amount per protein (Figure 2c).
We next assessed the pattern of changes in individual lipid
species in each lipid class. Among lipid classes we analyzed, LPS
species were almost uniformly upregulated (Figure 2d). However,
most of the upregulated DAG species had zero, one or two
carbon-carbon double bonds, while those with more than three
double bonds had no change (Figure 2e). This pattern appeared to
be obvious when all the species were re-aligned according to the
mean fold change in each DAG species between Rb-depleted and
control MEFs (Figure 2f). VIP score analysis exhibited a similar
trend (Supplementary Figure S2a). Hierarchial clustering analysis
of DAG species indicated that independent clusters might reﬂect
the difference in the number of carbon–carbon double bonds
(Supplementary Figure S2b). These data support the idea that Rb
depletion increased a series of DAG species of particular number
of carbon–carbon double bonds, and the change in these DAG
species accounts for the increase in the total amount of DAG.
Next, we assessed the acyl chain composition of each DAG
species according to the data acquired by linear ion trap data-
dependent MS/MS (Supplementary Table S3). We observed an
increase in DAG 36:1 (16:0/20:1 or 18:0/18:1) and DAG 36:2
(18:1/18:1) in Rb-depleted MEFs (Figure 2g). In contrast, DAG 36:3
(16:0/20:3 or 18:1/18:2) was not inﬂuenced by Rb depletion
(Figure 2g). These data indicate that Rb depletion increased
particular DAG species composed of C16:0, C18:0 or C18:1 acyl
chains. This idea was further supported by the data of the
other DAG species with different carbon length (Supplementary
Table S3).
We then assessed whether any changes in acyl chain
composition occur in other lipid class especially DAG-derived
lipid metabolites upon Rb depletion. We found that among
glycerophospholipids derived from DAG, PC and phosphatidylser-
ine showed a pattern similar to that was seen in DAG
(Supplementary Figures S3a and b). Other lipids, however, showed
different patterns of changes (Supplementary Figures S3c–h).
The amount of total MAG was downregulated (Figure 2h).
However, we noticed that MAG 18:1 in particular was upregulated.
Similarly, hexosyl-ceramide (HexCer) was mostly downregulated
but HexCer (d18:1/18:0) was upregulated (Figure 2i). These
ﬁndings suggest that the distinct pattern of changes in acyl chain
composition induced upon Rb depletion is shared by multiple lipid
species regardless of change in total amount.
Rb depletion induces a distinct qualitative change in fatty acids
We sought a possible mechanism underlying the distinct
qualitative changes in multiple lipid species that appeared upon
Rb depletion. Since the pattern that appeared in multiple lipid
species entails an increase in the levels of fatty acyl chains with a
speciﬁc number of carbons and carbon–carbon double bonds, we
focused on the fatty acids composition. With respect to the robust
quantitative variability in fatty acids with different carbon
length and degrees of unsaturation, we compared the absolute
concentrations of each species. We found that the absolute
amount of FA 16:0 and FA 18:1 signiﬁcantly increased (Figure 3a).
We also observed an increase in FA 18:0 but with poor statistical
signiﬁcance in this assessment. Among fatty acids present to a
smaller amount, we observed signiﬁcant increase in FA 14:0,
FA 16:2, FA 17:0 and FA 20:2 upon Rb depletion (Figure 3a).
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The heat map of the VIP projection analysis showed the highest
score for FA 18:1 (Supplementary Figure S4a). We then quantiﬁed
all forms of FA 18:1 (Figure 3b). Cis-vaccenic acid (18:1 n-7, cis),
vaccenic acid (18:1 n-7, trans), oleic acid (18:1 n-9, cis) and elaidic
acid (18:1 n-9, trans) were all signiﬁcantly upregulated upon
Rb depletion (Figure 3c).
Since glycerophospholipids are formed by the association of
glycerols and fatty acids, we thought that an increase in the levels
of particular glycerophospholipids might be explained by higher
levels of particular fatty acids. We conducted a correlation
coefﬁcient analysis for DAG 34:1, DAG 36:1 and DAG 36:2 that
were signiﬁcantly increased by Rb depletion. We found that an
increase in the levels of FA 18:1 has a strong correlation with the
increase in the levels of these DAGs (Supplementary Figure S4b).
In addition, the correlation coefﬁcient analysis indicated a strong
positive correlation between FA 18:1 and several lipid species
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Figure 1. Lipidomic proﬁling of Rb-depleted MEFs. (a) RT–qPCR of Rb1 in wild-type MEFs infected with lentiviruses expressing the indicated
shRNAs and selected. Cells were cultured in the medium containing 1% FBS for 24 h. Data represent mean+s.d. Four batches of MEFs derived
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DA of 199 lipids. Red and green indicate increased and decreased levels, respectively. (f) Volcano plot of lipids with VIP41. Important lipids
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with red and those with Po0.01 and |FC|42 were labeled. (g) Levels of the indicated lipids in control MEFs (solid) and
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possibly composed of FA 18:1 including DAG 36:1, DAG 36:2
and DAG 34:1 (Supplementary Figure S4c). All these ﬁndings
suggest that an increase in the levels of particular fatty acids
upon Rb depletion is strongly correlated with an increase of
glycerophospholipids with speciﬁc fatty acyl chains.
The pathway leading to FA 18:1 synthesis includes FA 14:0,
FA 16:0 and FA 18:0; the elongation and desaturation of all
these lipids are performed by the two enzymes Elovl6 and Scd1
(Figure 3b). The ﬁndings of our lipidomic analyses indicated that
Elovl6 and Scd1 might be upregulated by Rb depletion.
Rb regulates transcription of Elovl6 and Scd1
To speciﬁcally determine the role of Rb in lipid metabolism, we
conducted a microarray analysis of Rb-depleted MEFs (Rb shRNA1)
(Supplementary Table S4). The signature obtained from the
comparison of Rb-depleted and control MEFs was signiﬁcantly
similar to an RB inactivation signature determined in a previous
work30 when assessed by Gene Set Enrichment Analysis,
suggesting that Rb depletion was successful (Figure 4a). As
expected, Gene Ontology analysis of the signature contained
Kyoto Encyclopedia of Genes and Genomes pathway terms
related to cell cycle and DNA synthesis with high signiﬁcance
(Supplementary Table S5). We then selected gene sets related
to lipid metabolism from our RB inactivation signature, and
applied them to Gene Ontology analysis again (Figure 4b and
Supplementary Table S6). We consequently found that a series of
genes involved in the biosynthesis of unsaturated fatty acids
including Elovl6 and Scd1 were signiﬁcantly upregulated following
Rb depletion (Figure 4b). We conﬁrmed this ﬁnding by conducting
reverse transcription and real-time quantitative PCR (RT–qPCR);
Elovl6 and Scd1 were robustly upregulated in Rb-depleted MEFs
(Figure 4c). The increase in FA 16:0 can be explained by the
increased de novo fatty acid synthesis. Thus in addition to Elovl6
and Scd1, we conducted an RT–qPCR of Acly, Acaca and Fasn
(Figure 3b). All these enzymes were slightly but signiﬁcantly
increased upon Rb depletion (Figure 4c and Supplementary
Table S7). Immunoblotting partially conﬁrmed our RT–qPCR results
(Figure 4d). Additionally, we analyzed MEFs in which Rb is
depleted using another shRNA (Rb shRNA2). Rb shRNA2 down-
regulated Rb1 expression to a lesser extent than shRNA1 did. This
resulted in a weaker upregulation of Elovl6 and Scd1, conﬁrming
that these genes were not upregulated because of off-target
effects of shRNAs (Supplementary Figure S5a). We also analyzed
MEFs derived from another pair of Rb− /− and Rb+/+ mouse
embryo. The results were highly consistent with the analysis using
Rb-depleted MEFs (Figure 4e and Supplementary Figure S5b).
Moreover, analysis of our and other’s previous microarray data
acquired in Rb-deﬁcient or RB overexpression contexts identiﬁed
Elovl6 and Scd1 as likely targets of Rb (Supplementary Table S8).
Finally, luciferase reporter assay revealed that RB signiﬁcantly
suppressed Elovl6 and Scd1 promoter activity (Figure 4f). Taken
together, these ﬁndings suggest that Rb status affects the
expression of several genes involved in fatty acid synthesis,
elongation and desaturation; among them, Elovl6 and Scd1 are the
ones most robustly affected.
Possible involvement of E2Fs and SREBPs in the transcriptional
control of Elovl6 and Scd1
We next addressed the mechanism by which Rb controls the
expression of Elovl6 and Scd1. Since we had previously linked Rb
to N-Ras maturation through SREBP-dependent regulation of
isoprenylation-related genes,12 we assessed the status of SREBP-1
and 2 in Rb-depleted MEFs. Unlike previously investigated C cells,
Rb depletion in MEFs only slightly increased the transcription of
Srebf2, but not Srebf1 (Figure 5a). When we compared Rb− /− MEFs
to littermate Rb+/+ MEFs, Srebf1 expression was increased in cells
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lacking Rb (Supplementary Figure S5c). Surprisingly, we however
observed that the nuclear form of SREBP-1 was signiﬁcantly
enhanced both in Rb-depleted MEFs and in Rb− /− MEFs compared
to their control cells (Figure 5b and Supplementary Figure S5d).
Among the regulators of SREBP nuclear translocation, Insig2 was
downregulated both in Rb-depleted MEFs and in Rb− /− MEFs
compared to control cells (Supplementary Figures S5e and f).
Furthermore, nuclear translocation of SREBP-1 induced by Rb
depletion was antagonized by fatostatin treatment, which inhibits
nuclear translocation of SREBPs (Figure 5c). Thus, although the
effects of knockdown and knockout were somewhat different,
we conclude that Rb depletion in MEFs promotes nuclear
translocation of SREBP-1. Additionally, fatostatin signiﬁcantly
antagonized Rb depletion-induced upregulation of Elovl6 but
not Scd1 (Figure 5d). Collectively, these results indicate that Rb
inactivation increases Elovl6 gene expression through SREBP-1
activation.
Since we identiﬁed a number of RB partner E2F-binding
consensus sequences in addition to sterol regulatory elements
in the promoter region of these genes both in mice and human
(Supplementary Figure S6a and Supplementary Table S9) and
Gene Set Enrichment Analysis indicated that Rb depletion in MEFs
signiﬁcantly induced upregulation of E2F targets (Supplementary
Figure S6d), we addressed the possibility that Elovl6 and/or Scd1
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Figure 5. The mechanism whereby Rb regulates Elovl6 and Scd1 gene expression. (a) RT–qPCR of the indicated genes in wild-type MEFs
infected with lentiviruses expressing the indicated shRNAs and selected. Cells were cultured in the medium containing 1% FBS for 24 h.
Data represent mean+s.d. Four batches of MEFs derived from one embryo were used per one shRNA. *Po0.05, **Po0.01 by Student’s t-test.
(b) IB of the indicated proteins in wild-type MEFs transduced with the indicated shRNA and cultured in the medium containing 1% FBS for
24 h. Full-length of SREBP-1 (ﬂ) and nuclear SREBP-1 (n) were separated. (c) IB of the indicated proteins in wild-type MEFs transduced with the
indicated shRNA and cultured in the medium containing 1% FBS for 24 h with or without SREBP inhibitor fatostatin (20 μM) for last 6 h.
(d) RT–qPCR of the indicated genes in wild-type MEFs infected with lentiviruses expressing the indicated shRNAs and selected. Cells were
cultured in the medium containing 1% FBS for 24 h with or without fatostatin (20 μM) for last 6 h. Data represent mean+s.d. Three batches of
MEFs derived from one embryo were used per one shRNA. *Po0.05, **Po0.01 by Student’s t-test. (e) RT–qPCR of the indicated genes in
Rb− /− MEFs transfected with pCMV vectors expressing the indicated proteins. Data represent mean+s.d. (n= 3) *Po0.05, **Po0.01 by
Student’s t-test. (f) Luciferase activity in HepG2 cells transfected with pGL3 containing the indicated luciferase reporters together with
pCMV-β-gal and pCMV vectors expressing the indicated proteins. Results are normalized to β-gal activity. Data represent mean+s.d. (n= 3)
*Po0.05, **Po0.01 by Student’s t-test. (g) IB of the indicated proteins in wild-type MEFs transduced with the indicated shRNA and cultured in
the medium containing 1% FBS for 24 h with or without HLM006474 (30 μM). (h) Association of E2F1, E2F2 and E2F3 with the promoters of the
mouse Elovl6, Scd1, Cdc6 (positive control) and Fscn2 (negative control) was assessed by ChIP in Rb− /− MEFs. Input or eluted chromatin was
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t-test. FBS, fetal bovine serum.
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are directly regulated by E2Fs. This idea is supported by the
ﬁnding that Rb depletion can induce both Elovl6 and Scd1 in
Srebf1− /− MEFs (Supplementary Figure S6b). In addition, depletion
of Srebf2 could not antagonize Rb depletion-induced upregulation
of Elovl6 and Scd1 (Supplementary Figure S6c). Overexpression of
individual transactivating E2F family members indicated the
possibility that both Elovl6 and Scd1 genes are sensitive to
overexpression of some of the RB partner E2Fs (Figure 5e).
Furthermore, E2F2 and E2F3 enhanced the luciferase activity of
both Elovl6 and Scd1 (Figure 5f). Importantly, we discovered that
nuclear translocation of SREBP-1 induced by Rb depletion was
signiﬁcantly antagonized by an E2F inhibitor HLM006474,
indicating that SREBP-1 nuclear translocation depends on E2Fs
(Figure 5g). We then performed chromatin immunoprecipitation
(ChIP) assay to assess direct regulation of Elovl6 and Scd1 gene by
E2Fs. We found that E2F3 occupies the proximal promoter of both
Elovl6 and Scd1 with a statistical signiﬁcance (Figure 5h). We also
found that E2F1 occupies Elovl6 promoter and E2F2 occupies
Scd1 promoter to a lesser extent, but with a statistical signiﬁcance.
ChIP assay of E2Fs binding to a known target Cdc6 promoter
(positive control) showed all of E2F1, E2F2 and E2F3 occupy it.
In addition, none of them interacted with Fscn2 gene promoter
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Figure 6. Effects of inhibition of de novo MUFAs synthesis on sphere formation induced by Rb inactivation. (a) Sphere assay of RN6 cells
infected with pLXSB vectors expressing the indicated proteins and selected. 2 × 103 cells were seeded and sphere images were acquired after
7 days. Scale bars, 1,500 μm (top) and 300 μm (bottom). Data represent mean+s.d. (n= 4). *Po0.05, **Po0.01 by Student’s t-test. (b) Tumors
developed in KSN/Slc mice transplanted with RN6 cells transduced with the indicated expression vectors and selected. 1 × 104 cells were
injected subcutaneously into male KSN/Slc mice. Tumors were weighed 46 days after injection. Data represent mean+s.d. (n= 4) *Po0.05,
**Po0.01 by Student’s t-test. (c, d) RT–qPCR of the indicated genes in RN6 cells transduced with the indicated proteins and cultured under
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KSN/Slc mice. Tumors were weighed 46 days after injection. Data represent mean+s.d. (n= 4) *Po0.05, **Po0.01 by Student’s t-test. MUFA,
mono-unsaturated fatty acid.
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(negative control). These results are consistent with our other data,
indicating that E2F3 had a strongest effect on Elovl6 and Scd1
gene expression (Figures 5e and f). Taken together, these ﬁndings
suggest the involvement of E2Fs in the transcriptional control of
Elovl6 and Scd1.
Elovl6 and Scd1 depletion suppresses the malignant phenotype of
Rb-deﬁcient cells
Given the genetic interactions between Rb and Elovl6, and
between Rb and Scd1, we ﬁnally examined whether Elovl6 and
Scd1 contribute to the malignant behavior of Rb-deﬁcient cells.
To this end, we employed RN6 cells derived from Rb− /−; N-ras− /−
MEFs that spontaneously acquired a loss of function mutation in
Trp53.29 This line exhibits a carcinogenic phenotype represented
by an enhanced ability to form spheres, colonies and tumors in an
Rb-dependent manner (Figures 6a and b and Supplementary
Figures S7a). Overexpression of RB signiﬁcantly suppressed these
phenotypes. We found that Elovl6 and Scd1 expression was
downregulated upon overexpression of RB in RN6 cells under both
monolayer and sphere culture conditions (Figures 6c and d).
It was previously reported that RN6 cells cultured under sphere-
forming conditions showed increased expression of Nanog and
Sox2 when compared to cells grown under monolayer culture
condition.29 We observed a signiﬁcant upregulation of Elovl6 and
Scd1 in sphere cultures, implicating that these enzymes might
positively contribute to the self-renewal stimulated by Rb
deﬁciency (Supplementary Figures S7b). To test this hypothesis,
we depleted either Elovl6 or Scd1 in RN6 cells (Supplementary
Figure S7c). This resulted in signiﬁcant suppression of sphere
formation (Figure 6e). Moreover, depletion of either Elovl6 or Scd1
in RN6 cells resulted in signiﬁcant attenuation of colony
formation and tumor initiation in immune-compromised mice
(Supplementary Figures S7d and Figure 6f). A chemical inhibitor of
SCD1 (MF-438) almost completely suppressed sphere formation
by RN6 cells in consistent with the knockdown results
(Supplementary Figure 7e). Moreover, the effect of this agent
was rescued by supplementation of bovine serum albumin-
conjugated mono-unsaturated fatty acids (FA 16:1 or FA 18:1) but
not by supplementation of saturated fatty acids (FA 16:0 or FA
18:0). These ﬁndings indicate that desaturation of fatty acids may
contribute to the malignant behavior of cancer cells induced by
Rb loss.
Correlation of RBmutation with ELOVL6 and SCD1 gene expression
in human cancer patients
To investigate whether the regulation of Elovl6 and Scd1 gene
expression by Rb is applicable to human cancer patients,
we analyzed cBioPortal database. Remarkably, ELOVL6 and SCD1
exhibited signiﬁcantly higher expression levels in mutant RB
tumors compared to those bearing wild-type RB in breast cancer
and ovarian cancer patients (Supplementary Figure S8).
DISCUSSION
RB inactivation during tumor progression is correlated with
the gain of malignant features by cancer cells such as
epithelial–mesenchymal transition, undifferentiated phenotypes,
angiogenesis, metastasis and therapy resistance.1 Gene products
or metabolites that quantitatively or qualitatively change in
correlation with the RB status in these phenomena might contain
novel therapeutic targets for cancer.5–10 We therefore have been
determining the Rb inactivation signatures of mRNA, microRNA
and metabolites in various cellular contexts.31,32 In the current
study, by employing an advanced lipidomics technique, we
succeeded in determining a lipidomic signature associated with
Rb inactivation.
Recently, lipidomics techniques have been applied to
cancer studies by an increasing number of researchers.21–27 The
mechanisms by which the activation of oncogenes or the
inactivation of tumor suppressor genes promote deregulated
lipid metabolism in tumor cells are becoming clearer.33–36 In this
study, we employed an advanced lipidomics method called
scheduled multiple reaction monitoring that can simultaneously
detect and quantify thousands of fatty acid metabolites without
deterioration of data quality. This is enabled by the MS/MS
scanning technique for determining choromatographic elution
peak of each target lipid molecule that can be achieved within a
short time (2 ~ 3 min).
Our results demonstrated that changes in the Rb status gives
rise to a profound impact on the lipidomic signature. Rb depletion
in MEFs caused a signiﬁcant increase in LPS, DAG, FA, AcCar,
PC and ethanolamine, and signiﬁcant decrease in phosphatidyl-
glycerol and MAG, without changes in the total lipid amount per
protein. We observed a unique change in acyl chain composition
in multiple lipid classes including DAG, PC and phosphatidylserine.
This change can be at least partially explained by the changes in
the FA composition, since the proﬁle of acyl chains in these lipid
classes are similar to FA composition; we observed increased
levels of myristic acid (14:0), palmitic acid (16:0), stearic acid (18:0)
and all forms of FA 18:1. As membrane phospholipids are
constantly synthesized and remodeled, it is reasonable that the
changes in the FA composition affect the acyl chain composition
of these lipid classes. Furthermore, increased FA production and
changes in FA composition can be explained by the accelerated
elongation and desaturation of fatty acids because of an elevated
transcription of Elovl6 and Scd1 induced by Rb depletion.
Inhibition of either ELOVL6 or SCD1 was in fact reported to
largely affect the composition of fatty acids and phospholipids in
cancer cells.27,37 Therefore, transcriptional regulation of Elovl6 and
Scd1 might explain the Rb function in the control of lipid
metabolism to a large extent.
We observed that nuclear translocation of SREBP-1 is enhanced
by Rb depletion in MEFs in an E2F-dependent manner. The
promoter region of mouse Elovl6 and Scd1 possess both E2F and
SREBP-binding sequences, and indeed ChIP assay demonstrated
the direct involvement of E2Fs in the transcriptional regulation of
Elovl6 and Scd1. These ﬁndings indicate an intimate coordination
of E2Fs and SREBPs in the control of lipid metabolism by RB.
Increase in DAG might also be explained by elevated
Lpin1 transcription (Supplementary Table S4), whose product
synthesizes DAG from PA.38 In addition to Elovl6, Scd1 and Lpin1,
our microarray analysis of Rb-depleted MEFs detected changes in
the expression levels of many genes related to lipid metabolism;
the biological signiﬁcance will be investigated in the future. As of
now, it would be useful to assess the effect of upregulated DAG on
cellular signaling, as it functions as a second messenger.39
Changes in the acyl chain composition of membrane lipids such
as PC might affect the topology or activity of membrane proteins
by altering local membrane structure or thickness.40–42 In future
we will study whether the Rb status can affect these features
through the control of lipid metabolism.
There are a few previous studies that connected Rb to lipid
metabolism. Our group reported that Rb regulates many enzymes
implicated in the mevalonate and lipid synthesis pathways
through E2Fs and SREBPs.12 In addition, it was shown that E2F1
participates in the control of fatty acid metabolism in Sonic
hedgehog (Shh)-driven mice medulloblastoma.43 This work
demonstrated that Sonic hedgehog signaling triggers de novo
fatty acid synthesis through the Sonic hedgehog-Rb/E2F1-FASN
axis while suppressing fatty acid oxidation. Recently, another
group suggested that E2F1 regulates lipogenesis thereby con-
tributing to mouse liver steatosis.44 The same body of work
demonstrated that loss of E2f1 suppresses the expression of
lipogenic genes including Acaca, Fasn, Scd1, Srebp1c and Chrebp in
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mouse livers and primary hepatocytes, supporting our
current work.
We ﬁnally demonstrated that inhibition of Elovl6 and Scd1
suppresses malignant phenotypes induced by Rb inactivation.
Since RB is frequently inactivated during tumor progression, these
two enzymes can be promising therapeutic targets. Regarding
SCD1, numerous studies already reported its clinical relevance.
Inhibition of SCD1 in cancer cells induces apoptosis by inducing
ER stress or cytochrome c release.27,45,46 In other contexts,
inhibition of SCD1 causes growth suppression by attenuating
EGFR phosphorylation or palmitoylation of WNT3A.47,48 ELOVL6 is
overexpressed in several cancers including nonalcoholic
steatohepatitis-related hepatocellular carcinoma,49,50 squamous
cell carcinoma37 and breast cancer,51 although the mechanism of
its role in cancer cells is not yet clear. Mice homozygously deﬁcient
for these genes are viable.52–54 Hence, inhibitors of these enzymes
might exhibit tumor-speciﬁc effects. Taken together, our current
work highlights a critical role for Rb in the control of lipid
metabolism and, by a comprehensive approach combining
lipidomics and transcriptomics, identiﬁes lipid metabolism
enzymes as possible therapeutic targets.
MATERIALS AND METHODS
Animals
Rb+/− mice were obtained from Dr T. Jacks.55 Srebf1− /− mice were
obtained from Dr H. Shimano.56 All animals were handled in accordance
with the guidelines of Kanazawa University.
Generation and culture of MEFs
MEFs were isolated from littermate wild type, Rb− /− embryos and Srebf1− /−
embryos as described previously,57 and maintained in α modiﬁed Eagle’s
medium (MEMα, #135-15175, Wako, Osaka, Japan) supplemented with
10% fetal bovine serum and 1% phosphatidylserine.
Virus production and transduction
Lentivirus or retrovirus production and transduction were performed
as described previously.12,29 MISSION TRC shRNA target sets used in this
study were purchased from Sigma-Aldrich (St Louis, MO, USA) and shown
in Supplementary Materials and Methods. pLXSB, pLXSB-RB, pLenti6.3/V5-
LacZ and pLenti6.3/V5-HA-RB were described previously.12,29
Lipidomics
MEFs were grown in MEMα with 1% fetal bovine serum for 24 h,
trypsinized, and collected in complete culture medium. The collected cells
were washed two times with PBS, isolated by centrifugation, and stored at
− 80 °C before lipid extraction. Next, samples were mixed with 300 μl
methanol containing 1% acetic acid and sonicated on ice, followed by the
addition of 2 ml of a 1:2:2 mixture of chloroform:methanol:ethanol
containing the internal standards and 100 μl of a 2:1:1:1 mixture of
chloroform:methanol:ethanol:acetic acid. The mixture was vortexed at
room temperature, centrifuged for 10 min at 4 °C; the organic layer was
collected, evaporated under reduced pressure and dissolved in 280 μl
reconstitution solution of which 4 μl was analyzed by LC-MS/MS. After the
data pre-processing, lipids with s.d.⩾ 30% were removed and top 10 lipids
with highest quantity in each lipid class were selected. Finally 199 lipids
were used for further analysis. Principal component analysis, partial least
square discriminant analysis, hierarchical clustering (dendrogram and heat
map) and correlation analysis were performed by MetaboAnalyst 3.0
(http://www.metaboanalyst.ca/).58 For more information about LC-MS/MS
analysis, see Supplementary Materials and Methods.
RT–qPCR
Total RNA extraction, RT and qPCR were performed as described
previously.29 TaqMan probes used in this study are shown in
Supplementary Materials and Methods. The mRNA levels were normalized
to Actb or Hprt mRNA levels.
Immunoblotting
Immunoblotting of whole-cell lysates and nuclear fraction was performed
as described previously.57 Antibodies used in this study are shown in
Supplementary Materials and Methods. Quantiﬁcation of the band
intensity was performed by ImageJ Version 1.45s software.
Luciferase assay
MEFs and HepG2 cells were co-transfected with pGL3-mouse Elovl6 or
pGL3-mouse Scd1 (gifted by Dr Shimano),59 pCMV-β-gal and the indicated
vectors using Lipofectamine 3000 (L3000-015, Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. Luciferase and β-gal
activities were determined as described previously.11 Luciferase activities
were then normalized by the β-gal activities. pCMV, pCMV-E2F1 (#24225),
pCMV-E2F2 (#24226), pCMV-E2F3a (#37970) and pCMV-E2F3b (#37975)
were purchased from Addgene (Cambridge, MA, USA).
Cross-linked ChIP
ChIP experiments using MEFs were performed as previously described60
with some modiﬁcations. For more information, see Supplementary
Materials and Methods.
Sphere formation assay
RN6 cells derived from Rb− /−; N-ras− /− MEFs that spontaneously acquired a
loss of function mutation in Trp53 were used.29 This line exhibits a
carcinogenic phenotype represented by an enhanced ability to form
colonies and tumors in an Rb-dependent manner. Sphere formation assay
was carried out as previously described.29 Where indicated, sphere cultures
were supplemented with bovine serum albumin or 10 μM bovine serum
albumin-conjugated fatty acids in the presence of dimethylsulphoxide or
10 μM MF-438. Free fatty acids were conjugated with fatty acid-free bovine
serum albumin using the method described previously.61 After 7 days of
culture, sphere images were acquired using a BZ-8000 microscope
(Keyence, Osaka, Japan) and sphere area was analyzed using BZ-II Analyzer
(Keyence).
Colony formation assay
1× 103 cells were seeded into 60 mm dishes. After 10 days of culture,
colonies were stained with Giemsa solution (#1.09204.0100, MERCK,
Darmstadt, Germany) and positive area for Giemsa staining was quantiﬁed
by ImageJ Version 1.45s software.
Xenograft assay
1× 104 cells were suspended in 50 μl MEMα and mixed with the
same volume of Matrigel (#354234, CORNING, Corning, NY, USA). Mixtures
were injected subcutaneously into male KSN/Slc mice (Japan SLC, Inc.,
Shizuoka, Japan). Tumors were weighed at 46 days after injection.
Statistical analysis
Statistical signiﬁcance for the relative lipids amount, mRNA expression and
area of spheres, colonies were determined using unpaired Student’s t-test.
For more information, see Supplementary Materials and Methods.
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